IL10 and Salla disease: Conversely, the decreased NO levels in SD may be related to the inhibitory effect on signal transduction for iNOS and NO production induced by the anti-inflammatory cytokines released in the symptomatic active form of the disease, such as IL-4, IL-10, IL-13, or TGF-β [46].